GlaxoSmithKline: all 4,196 studies
Page 33 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- DDI Study of Etravirine and GSK1265744CompletedNCT00920296Phase 1
- A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795CompletedNCT00920257Phase 1
- Safety Study of Foretinib (GSK1363089) in Adults With Liver CancerCompletedNCT00920192Phase 1
- Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe DrugsCompletedNCT00920088Phase 1
- Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular CarcinomaCompletedNCT00911196
- Effects of GSK598809 on Brain Activation in Abstinent AlcoholicsWithdrawnNCT00908206Phase 1
- A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy SubjectsTerminatedNCT00907985Phase 1
- Intranasal SB-705498 in Healthy VolunteersCompletedNCT00907933Phase 1
- Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)CompletedNCT00903422Phase 1
- A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy SubjectsCompletedNCT00896558Phase 1
- A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic ChemotherapyWithdrawnNCT00891761Phase 3
- CR9112792, a Follow-up of Study CR9108963CompletedNCT00891553
- EtOH Interaction StudyCompletedNCT00887367Phase 1
- QTc Study of Rosi XR in Healthy VolunteersWithdrawnNCT00884533Phase 1
- GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and AtazanavirCompletedNCT00883935Phase 1
- ARI103094-Follow-Up Study for REDUCE Study SubjectsCompletedNCT00883909
- Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib VaccineCompletedNCT00880477Phase 3
- A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid TumorsCompletedNCT00880321Phase 1
- Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsCompletedNCT00879827Phase 3
- An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)CompletedNCT00875784Phase 1
- First Time in Human Study of GSK1223249 in Amyotrophic Lateral SclerosisCompletedNCT00875446Phase 1
- Tafenoquine/Chloroquine DDI StudyCompletedNCT00871156Phase 1
- GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/RitonavirCompletedNCT00867152Phase 1
- Observational Study of Nelarabine in Children and Young AdultsCompletedNCT00866671
- A Study for Evaluation of GSK Biologicals' Pandemic Influenza VaccineWithdrawnNCT00866580Phase 3
- Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT00866528Phase 1
- Drug Interaction Study to Investigate Co-administration of GW642444M With KetoconazoleCompletedNCT00866515Phase 1
- The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With GastroparesisCompletedNCT00861809Phase 2
- Proof of Mechanism in ELTCompletedNCT00861484Phase 1
- VEG111485: A QTc Study of PazopanibCompletedNCT00861029Phase 1
- A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572CompletedNCT00858455Phase 1
- A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.CompletedNCT00858286Phase 4
- Analysis of Expression of Specific Markers in Hepatocellular CarcinomaCompletedNCT00858000
- A First-Time-In-Human Study in Healthy SubjectsCompletedNCT00857883Phase 1
- A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis BCompletedNCT00857675Phase 3
- Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With PlaceboCompletedNCT00851344Phase 2
- A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
- First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.CompletedNCT00849134Phase 1
- Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate VaccineTerminatedNCT00849069Phase 1
- Food and Relative Bioavailability StudyCompletedNCT00843011Phase 1
- Repeat Dose Safety Study for Compound to Treat AnemiaCompletedNCT00840320Phase 1
- BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress DisorderCompletedNCT00839397Phase 3
- Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.CompletedNCT00833378Phase 1
- Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawnNCT00832364Phase 4
- Single Dose Escalation First Time in Human PK StudyCompletedNCT00828867Phase 1
- GSK1349572 Mass Balance StudyCompletedNCT00828763Phase 1
- Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With PlaceboCompletedNCT00824356Phase 2
- A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal SubjectsCompletedNCT00823940Phase 1
- Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese VolunteersCompletedNCT00821535Phase 1
- A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer PatientsCompletedNCT00821054Phase 1
- Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsTerminatedNCT00820924Phase 2
- An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET LigandCompletedNCT00814957Phase 1
- Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years OldCompletedNCT00814762Phase 1
- Study to Evaluate GSK2190915 in Subjects With Mild AsthmaCompletedNCT00812773Phase 2
- Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.CompletedNCT00812318Phase 1
- A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat MalariaTerminatedNCT00811356Phase 1
- Repeat Dose Food Effect Study of GSK256073F in Healthy Adult SubjectsCompletedNCT00808093Phase 1
- A Healthy Volunteer Study With Inhaled GSK573719 and PlaceboCompletedNCT00803673Phase 1
- A Compassionate Access Protocol For Those Patients Who Have Completed A4001029No longer availableNCT00801515
- Relapse Prevention Study in Newly Abstinent SmokersWithdrawnNCT00793468Phase 2
- A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.CompletedNCT00783549Phase 1
- A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy SubjectsCompletedNCT00783003Phase 1
- Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWithdrawnNCT00782301Phase 4
- GSK1349572 Drug Interaction Study With Protease InhibitorsCompletedNCT00774735Phase 1
- GSK1349572 Drug Interaction Study With EtravirineCompletedNCT00774111Phase 1
- Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV VaccineCompletedNCT00757770Phase 3
- Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne VulgarisCompletedNCT00757523Phase 4
- Evaluation of Pneumococcal Vaccine Formulations in ElderlyCompletedNCT00756067Phase 1
- Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in GreeceCompletedNCT00751686
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy SubjectsCompletedNCT00750256Phase 1
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- PAXIL CR Bioequivalence StudyCompletedNCT00749359Phase 1
- Study in Mild Asthmatic PatientsCompletedNCT00748306Phase 2
- A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848CompletedNCT00743860Phase 1
- Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy SubjectsCompletedNCT00743405Phase 1
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid TumorsCompletedNCT00743067Phase 1
- A Bioavailability Study of GSK1363089 in Subjects With Solid TumorsCompletedNCT00742261Phase 1
- Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00742144Phase 1
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid TumorsCompletedNCT00742131Phase 1
- PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy VolunteersCompletedNCT00733785Phase 1
- A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.CompletedNCT00733577Phase 1
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.CompletedNCT00733551Phase 1
- Open-label Study of Topotecan and Pazopanib in Advanced Solid TumorsCompletedNCT00732420Phase 1
- Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04CompletedNCT00731393Phase 3
- A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge ModelCompletedNCT00731250Phase 1
- Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03CompletedNCT00731029Phase 3
- Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative AdultsCompletedNCT00730795Phase 1
- Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.CompletedNCT00729001Phase 2
- A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules.CompletedNCT00728897Phase 1
- GSK372475 PK Study in Healthy VolunteersCompletedNCT00728208Phase 1
- A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy SmokersCompletedNCT00728052Phase 1
- Immunogenicity and Safety of GSK Biologicals' FluLaval® TFCompletedNCT00727428Phase 1
- GSK1349572 Drug Interaction With TenofovirCompletedNCT00726336Phase 1
- An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial AcneCompletedNCT00725439Phase 2
- An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00725348Phase 2
- GSK706769/KALETRA Drug-drug Interaction StudyCompletedNCT00723775Phase 1
- A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsCompletedNCT00722293Phase 1
- A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686CompletedNCT00721812Phase 1
- Maraviroc Compassionate UseWithdrawnNCT00719823Phase 3
- Study on Anti-inflammatory Effects of Topical R115866 GelCompletedNCT00719121Phase 1